Table 2.
Haplogroups | Observations | Reference |
---|---|---|
HV | Increased risk, especially in females | Maruszak et al. (2011) |
No effect | Elson et al. (2006), Maruszak et al. (2009) and Fachal et al. (2015) | |
H | Increased risk | Fesahat et al. (2007), Maruszak et al. (2009, 2011) and Coto et al. (2011) |
Defining SNP mt7028C increased risk | Coto et al. (2011) | |
Defining SNP mt7028C increased risk in females only | van der Walt et al. (2004) | |
H5 increased risk, especially in females | Santoro et al. (2010) | |
H5 and APOE4 synergistically increased risk | Maruszak et al. (2011) | |
H5a defining SNP mt4336C increased risk in APOE4 carriers | Edland et al. (2002) | |
H6a1a and H6a1b decreased risk | Ridge et al. (2012) | |
No effect | Chinnery et al. (2000), van der Walt et al. (2005), Mancuso et al. (2007) and Fachal et al. (2015) |
Effects of haplogroup H defining single nucleotide polymorphisms (SNPs) and its subhaplogroups are listed under haplogroup H.